Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis. [electronic resource]
- Cardiovascular research Mar 1997
- 666-70 p. digital
Publication Type: Journal Article; Meta-Analysis
0008-6363
10.1016/s0008-6363(96)00262-3 doi
Adenosine--metabolism Administration, Oral Angina Pectoris--drug therapy Angiogenesis Inducing Agents--administration & dosage Clinical Trials as Topic Collateral Circulation Coronary Circulation Coronary Disease--prevention & control Dipyridamole--administration & dosage Humans Time Factors